Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.18M Buy
687,112
+188,688
+38% +$1.73M 2.21% 16
2026
Q1
$4.63M Buy
+498,424
New +$4.9M 2.16% 24
2025
Q2
Sell
-352,280
Closed -$3.05M 67
2025
Q1
$3.05M Buy
+352,280
New +$3.69M 1.59% 35
2024
Q4
Sell
-317,739
Closed -$5.34M 58
2024
Q3
$5.34M Buy
317,739
+29,312
+10% +$482K 2.94% 6
2024
Q2
$4.51M Buy
288,427
+177,646
+160% +$2.47M 2.85% 8
2024
Q1
$1.75M Buy
+110,781
New +$1.85M 1.11% 41
2023
Q1
Sell
-181,875
Closed -$2.77M 55
2022
Q4
$2.77M Sell
181,875
-103,673
-36% -$1.48M 2.24% 17
2022
Q3
$3.99M Buy
+285,548
New +$5.75M 3.55% 5

Other funds holding NEOG

Roubaix Capital's NEOG Position: Q2 2026 in Review

Roubaix Capital increased its Neogen (NEOG) stake by 38% in Q2 2026, buying an estimated $1.73M and bringing the position to 687,112 shares worth $6.18M. The position accounts for 2.21% of the portfolio, ranked #16.

Roubaix Capital first reported a position in NEOG in Q3 2022 and has held it in 8 quarters since. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Roubaix Capital held 687,112 shares of Neogen worth $6.18M as of Q2 2026.
  • Roubaix Capital bought 188,688 Neogen shares in Q2 2026, an estimated $1.73M.
  • Neogen made up 2.21% of Roubaix Capital's portfolio in Q2 2026, its #16 holding.
  • Roubaix Capital first reported a position in Neogen in Q3 2022 and has held it in 8 quarters since.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Roubaix Capital's 13F filing for Q2 2026, filed 10 Aug 2026.